Exploring the cellular mechanisms of enhanced lifespan in bats
Exploring the cellular mechanisms of enhanced lifespan in bats
批准号:
10509822
负责人:
Vincent J. Lynch
金额:
$24.98万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-04-30
关键词:
Advanced DevelopmentAgeAgingAnimalsAntioxidantsBiological AgingBiological ModelsBiological ProcessBiologyBody SizeCell AgingCell Culture TechniquesCell LineCell modelCell physiologyCellsChiropteraChronologyCoupledDNA DamageDataDiseaseFamilyFemaleFertilityFoundationsFutureGoalsHealthHumanIndividualInvestigationLongevityMalignant NeoplasmsMammalian CellMammalsMetabolicMethodsMethylationMitochondriaModelingMorbidity - disease rateMusOrganismOxidative StressPhenotypePhysiological ProcessesPopulationProcessQuality of lifeResearchResearch PersonnelResourcesSamplingScientistStressStudy modelsSystemTaxonTimeTissue BanksTissuesVirusWorkZoonosesage relatedbasecell typehealthspanhealthy aginghuman old age (65+)induced pluripotent stem cellinsightmalemetabolic ratenovelresponsesenescencetheoriestooltrait
中文摘要
项目总结/摘要
人类衰老的特征是生物和生理过程的动态变化,
影响健康和生活质量。鉴于人口迅速老龄化,
这些负面影响是生物学日益紧迫的目标。实现这一目标的进展受到阻碍
由于通常使用的寿命较短的实验室动物(例如,鼠标)使不太理想的工具,
以确定驱动长寿哺乳动物(包括人类)长寿的过程。相反,蝙蝠,
为哺乳动物寿命提供了一个极好的研究系统。蝙蝠是最长寿的哺乳动物,
它们的体型和极端长寿在进化枝中至少进化了四次。许多蝙蝠也保持着
蝙蝠在其漫长的生命周期中保持健康;例如,蝙蝠表现出延长的生育能力,很少患癌症。
尽管这一群体有许多优势,但大多数蝙蝠实现其功能的细胞过程
惊人的长寿在很大程度上仍是未知的。这一疏忽的部分原因是,
由于许多蝙蝠缺乏明显的衰老迹象,
生物老化因此,对蝙蝠衰老的研究大多局限于少数几个物种,
或“标记和重新捕获”的殖民地已经维持了几十年,其中组织收集是
必须是最小的。该项目利用了一种新开发的基于甲基化的方法,
可靠地估计哺乳动物的实际年龄,包括野生蝙蝠,以克服这一障碍。这个新
这种方法将与野外和实验室对几个野生蝙蝠分支的研究相结合,以建立野生蝙蝠作为一种
在长寿的哺乳动物,如人类,细胞水平老化的强大模型,并使用此模型开始
以确定促进长寿和减轻衰老相关发病率的细胞过程。初步数据
表明蝙蝠通过几个细胞过程最大限度地减少DNA损伤和细胞水平的衰老,
所涉及的具体过程可能因蝙蝠而异。因此,每增加一只蝙蝠,
产生新颖和信息丰富的结果的潜力。该项目将通过完成两个
具体目标。目的1是表征和比较与衰老相关的细胞过程之间的关系,
和年代年龄的野生蝙蝠的组织从12个不同的物种从家庭Phyllostomidae,
包括长寿和短命的议员。目标2是功能性地操作和表征
衰老相关的细胞过程,如氧化应激,DNA损伤和衰老(除其他外),使用
在来自不同蝙蝠物种的原代和iPSC细胞上的标准哺乳动物细胞培养方法,包括那些
目标1的特征。通过完成这些目标,该项目预计将确定蜂窝
与野生蝙蝠的寿命相关并可减轻衰老相关的发病率的过程(例如,DNA
损伤、衰老)。有了这个关键的基础,这个项目是
预计将建立野生蝙蝠作为未来研究长寿哺乳动物细胞衰老的模型系统。
英文摘要
PROJECT SUMMARY/ABSTRACT
Human aging is characterized by dynamic changes in biological and physiological processes that negatively
impact health and quality of life. Given the rapidly aging human population, characterizing and mitigating
these negative impacts is an increasingly urgent goal of biology. Progress toward this goal has been hampered
by the fact that commonly used, shorter-lived lab animals (e.g., mouse) make less than ideal tools with which
to identify the processes that drive longevity in longer-lived mammals, including humans. Bats, in contrast,
provide an excellent study system for mammalian longevity. Bats are the longest-lived mammals relative to
their body size and extreme longevity evolved at least four times in the clade. Many bats also maintain their
health during their long lifespan; for example, bats display extended fertility and rarely if ever get cancer.
Despite the numerous advantages of the group, the cellular processes by which most bats achieve their
striking longevity remain largely unknown. This oversight has been driven, in part, by the inability of
researchers to accurately estimate the chronological age of wild bats, given many bats’ lack of obvious signs of
biological aging. As a result, studies of bat aging have been mostly limited to the few species for which captive
or “mark and recapture” colonies have been maintained for decades, and in which tissue collection is
necessarily minimal. This project takes advantage of a newly developed, methylation-based method that
reliably estimates chronological age across mammals, including wild bats, to overcome this obstacle. This new
method will be coupled with field- and lab- work on several clades of wild bats to establish wild bats as a
powerful model for cellular-level aging in long-lived mammals, such as humans, and use this model to begin
to identify cellular processes that drive longevity and mitigate aging-related morbidity. Preliminary data
suggest that bats minimize DNA damage and cellular-level aging through several cellular processes, and that
the specific processes involved likely vary from bat to bat. Each additional bat sampled therefore has the
potential to yield novel and informative results. This project will achieve its goals through completion of two
specific aims. Aim 1 is to characterize and compare the relationship between aging-related, cellular processes
and chronological age in the tissues of wild bats from twelve diverse species from the Family Phyllostomidae,
including longer and shorter -lived representatives. Aim 2 is to functionally manipulate and characterize
aging-relevant cellular processes such as oxidative stress, DNA damage, and senescence (among others) using
standard mammalian cell culture methods on primary and iPSC cells from diverse bat species, including those
characterized for Aim 1. Through completion of these aims, the project is expected to identify cellular
processes that are associated with longevity in wild bats and can mitigate aging-related morbidity (e.g., DNA
damage, senescence) when manipulated in cells grown in culture. With this critical foundation, this project is
expected to establish wild bats as a model system for future studies of cellular aging in long-lived mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the cellular mechanisms of enhanced lifespan in bats
-
批准号:10672324
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2022
-
负责人:Vincent J. Lynch
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: